THE INVOLVEMENT OF TRANSLOCATOR PROTEIN IN THE DORSAL ROOT GANGLION IN NEUROPATHIC PAIN

Bing-Jie MA,Xiao-Ming LIU,Ke MA
DOI: https://doi.org/10.3969/j.issn.1006-9852.2017.06.004
2017-01-01
Abstract:Objective: To investigate the role of translocator protein (TSPO) in the dorsal root ganglion (DRG) in neuropathic pain and to explore the possible mechanism. Methods: All male Sprague-Dawley rats were randomly assigned into 3 groups: the Sham group, the control group (SNI group) and the treatment group (Ro group). Vonfrey filaments were used to measure the 50% paw withdrawal thresholds (PWT). The expression of TSPO, BDNF and p-ERK in the DRG was detected by western blot and immunofluorescence. Results:① Compared with the Sham group, the expression of TSPO was increased in the SNI group (D7: P < 0.05, D14: P < 0.01). The TSPO signals were colocalized with IB4, CGRP, NF-200 positive neurons and S-100 positive glial cells. ② The PWT of SNI rats was significantly decreased compared with the sham group (P <0.01), which was reversed by intrathecal injection of ligand of TSPO (Ro5-4864) (D7: P < 0.01, D14: P <0.05). Furthermore, the expression of BDNF (P < 0.05), p-ERK1 (P < 0.01) and p-ERK2 (D7: P < 0.01, D14:P < 0.05) was declined in the Ro group. Conclusion: A single intrathecal injection of TSPO agonist Ro5-4864 attenuated mechanical allodynia in neuropathic pain. The mechanisms may be partly attributed to the inhibition of p-ERK and BDNF expression in the DRG.
What problem does this paper attempt to address?